Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine.

× No keyword cloud information.

23 in total

1. The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.

Authors: Taline V Khroyan; Willma E Polgar; Gerta Cami-Kobeci; Stephen M Husbands; Nurulain T Zaveri; Lawrence Toll
Journal: J Pharmacol Exp Ther Date: 2010-12-21 Impact factor: 4.030

2. 3D-QSAR studies of orvinol analogs as kappa-opioid agonists.

Authors: Wei Li; Yun Tang; Qiong Xie; Wei Sheng; Zhui-Bai Qiu
Journal: J Mol Model Date: 2006-03-22 Impact factor: 1.810

Review 3. Mu opioids and their receptors: evolution of a concept.

Authors: Gavril W Pasternak; Ying-Xian Pan
Journal: Pharmacol Rev Date: 2013-09-27 Impact factor: 25.468

4. Synthesis and opioid receptor binding of indium (III) and [¹¹¹In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors.

Authors: Shefali Srivastava; Emily A Fergason-Cantrell; Roger I Nahas; John R Lever
Journal: Tetrahedron Date: 2016-08-04 Impact factor: 2.457

Review 5. Maintenance medication for opiate addiction: the foundation of recovery.

Authors: Gavin Bart
Journal: J Addict Dis Date: 2012

Review 6. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence.

Authors: S M Crain; K F Shen
Journal: Neurochem Res Date: 1996-11 Impact factor: 3.996

7. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Authors: Marta Zielińska; Agata Jarmuż; Andrzej Wasilewski; Gerta Cami-Kobeci; Stephen Husbands; Jakub Fichna
Journal: Pharmacol Rep Date: 2016-12-05 Impact factor: 3.024

Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine.

2. 3D-QSAR studies of orvinol analogs as kappa-opioid agonists.

Review 3. Mu opioids and their receptors: evolution of a concept.

4. Synthesis and opioid receptor binding of indium (III) and [¹¹¹In]-labeled macrocyclic conjugates of diprenorphine: novel ligands designed for imaging studies of peripheral opioid receptors.

Review 5. Maintenance medication for opiate addiction: the foundation of recovery.

Review 6. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence.

7. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

8. Analgesic and dependence studies with oripavine partial agonists.

9. Microbiological transformation of 6,14-endo-ethenotetrahydrothebaine alkaloids.

10. Bacteriological studies with morphine-like narcotics: relevance to narcotic actions in mammals?